Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Journal of Pulmonology and Respiratory Diseases received 244 citations as per Google Scholar report
Non-Small Cell Lung Cancer (NSCLC) is the most common type of lung cancer, accounting for approximately 85% of cases. It encompasses several subtypes, including adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. NSCLC typically presents with symptoms such as persistent cough, chest pain, and weight loss. Diagnosis is often made through imaging and biopsy. Treatment options vary based on the stage and include surgery, chemotherapy, radiation therapy, and targeted therapies. Recent advances focus on personalized medicine and immunotherapy, aiming to improve outcomes and reduce side effects. Ongoing research is essential for developing novel treatments and improving patient prognosis.